Most of the drugs we’re excited about are very expensive and no affordable for many patients.

BISHAL GYAWALI
Department of Clinical Oncology and Chemotherapy Nagoya University School of Medicine

Madrid, 8 settembre 2017

ESMO 2017, Madrid: most of the drugs we’re excited about are very expensive and no affordable for many many patients and even for many governments in the world. Bishal Gyawali of Department of Clinical Oncology and Chemotherapy of Nagoya University School of Medicine talks us about innovation and affordability.

Altre interviste

Subscribe to newsletter